Nine Continents Medical→Coloplast
Acquisition · Cash · COLO-B · announced Nov 3, 2020
Announced
Nov 3, 2020
Closed
Nov 3, 2020
Economics
Cash()
Pre-deal · pre-deal mark: 2020, year precision · rounding grid ±$100M · Coloplast press release — Nine Continents Medical acquisition, 2020
$145M upfront + contingent milestone payment
Target
Nine Continents Medical
Pelvic Health · Clinical / therapeutic
HQ Dayton, OH · Founded 2014
Implantable tibial nerve stimulator (ITNS) for overactive bladder — miniaturized, self-powered device placed under local anesthesia; no patient activation or recharging required
- Globe Newswire — Coloplast press release (Nov 3, 2020)
Acquirer
Coloplast (COLO-B)
Pelvic Health
HQ Humlebæk, Denmark
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Implantable tibial nerve stimulator enters Coloplast into OAB 3rd-line therapy market — 80M+ people globally with OAB symptoms, ~3M candidates for device therapy
Evidence ladder
Secondary (press / IR)
Globe Newswire — Coloplast press release (Nov 3, 2020)
Limitations
- Single-source or weak corroboration — treat valuation and timing as directional.
- $145M upfront + contingent milestone payment
- Pre-deal valuation sourced from: Coloplast press release — Nine Continents Medical acquisition, 2020. Pre-deal market-cap and funding citations do not corroborate the acquisition.
Valuation peers · Pelvic Health
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer.
| Target | Acquirer | Announced | Value | Why included |
|---|---|---|---|---|
| Cogentix Medical | Laborie Medical Technologies | Mar 12, 2018 | same evidence class |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Nine Continents Medical (Pelvic Health). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v9 · updated 2026-09-20 · 1 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.